vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Kyivstar Group Ltd. (KYIV). Click either name above to swap in a different company.
Kyivstar Group Ltd. is the larger business by last-quarter revenue ($321.0M vs $185.2M, roughly 1.7× AMICUS THERAPEUTICS, INC.). Kyivstar Group Ltd. runs the higher net margin — 28.0% vs 0.9%, a 27.1% gap on every dollar of revenue. Kyivstar Group Ltd. produced more free cash flow last quarter ($311.0M vs $16.0M).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Kyivstar is a Ukrainian telecommunications operator offering fixed and mobile voice and data services, including 4G LTE, throughout Ukraine. The Kyivstar mobile network covers all cities of Ukraine, as well as more than 28,000 rural settlements, all major national and regional routes, most sea, and river coasts. As of 2024, Kyivstar served approximately 24 million mobile subscribers and over 1 million fixed-broadband customers. In 2024, Kyivstar partnered with Starlink to offer satellite-base...
FOLD vs KYIV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $321.0M |
| Net Profit | $1.7M | $90.0M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | 35.5% |
| Net Margin | 0.9% | 28.0% |
| Revenue YoY | 23.7% | — |
| Net Profit YoY | -88.5% | — |
| EPS (diluted) | $0.00 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $321.0M | ||
| Q3 25 | $169.1M | $297.0M | ||
| Q2 25 | $154.7M | — | ||
| Q1 25 | $125.2M | — | ||
| Q4 24 | $149.7M | — | ||
| Q3 24 | $141.5M | — | ||
| Q2 24 | $126.7M | — | ||
| Q1 24 | $110.4M | — |
| Q4 25 | $1.7M | $90.0M | ||
| Q3 25 | $17.3M | $-89.0M | ||
| Q2 25 | $-24.4M | — | ||
| Q1 25 | $-21.7M | — | ||
| Q4 24 | $14.7M | — | ||
| Q3 24 | $-6.7M | — | ||
| Q2 24 | $-15.7M | — | ||
| Q1 24 | $-48.4M | — |
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | 45.5% | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — | ||
| Q1 24 | 87.7% | — |
| Q4 25 | 8.6% | 35.5% | ||
| Q3 25 | 20.3% | -16.2% | ||
| Q2 25 | -6.1% | — | ||
| Q1 25 | -6.3% | — | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 11.8% | — | ||
| Q1 24 | -25.1% | — |
| Q4 25 | 0.9% | 28.0% | ||
| Q3 25 | 10.2% | -30.0% | ||
| Q2 25 | -15.8% | — | ||
| Q1 25 | -17.3% | — | ||
| Q4 24 | 9.8% | — | ||
| Q3 24 | -4.8% | — | ||
| Q2 24 | -12.4% | — | ||
| Q1 24 | -43.9% | — |
| Q4 25 | $0.00 | $0.41 | ||
| Q3 25 | $0.06 | $-0.41 | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $-0.02 | — | ||
| Q2 24 | $-0.05 | — | ||
| Q1 24 | $-0.16 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $455.0M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $1.3B |
| Total Assets | $949.9M | $2.1B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $455.0M | ||
| Q3 25 | $263.8M | $472.0M | ||
| Q2 25 | $231.0M | — | ||
| Q1 25 | $250.6M | — | ||
| Q4 24 | $249.9M | — | ||
| Q3 24 | $249.8M | — | ||
| Q2 24 | $260.1M | — | ||
| Q1 24 | $239.6M | — |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $1.3B | ||
| Q3 25 | $230.4M | $1.2B | ||
| Q2 25 | $204.3M | — | ||
| Q1 25 | $193.6M | — | ||
| Q4 24 | $194.0M | — | ||
| Q3 24 | $178.8M | — | ||
| Q2 24 | $132.5M | — | ||
| Q1 24 | $130.7M | — |
| Q4 25 | $949.9M | $2.1B | ||
| Q3 25 | $868.8M | $2.0B | ||
| Q2 25 | $815.3M | — | ||
| Q1 25 | $789.8M | — | ||
| Q4 24 | $785.0M | — | ||
| Q3 24 | $786.6M | — | ||
| Q2 24 | $749.5M | — | ||
| Q1 24 | $721.8M | — |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $558.0M |
| Free Cash FlowOCF − Capex | $16.0M | $311.0M |
| FCF MarginFCF / Revenue | 8.6% | 96.9% |
| Capex IntensityCapex / Revenue | 0.2% | 76.9% |
| Cash ConversionOCF / Net Profit | 9.62× | 6.20× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $558.0M | ||
| Q3 25 | $35.7M | $406.0M | ||
| Q2 25 | $-26.5M | — | ||
| Q1 25 | $7.8M | — | ||
| Q4 24 | $-3.9M | — | ||
| Q3 24 | $-23.0M | — | ||
| Q2 24 | $22.7M | — | ||
| Q1 24 | $-29.7M | — |
| Q4 25 | $16.0M | $311.0M | ||
| Q3 25 | $35.3M | $250.0M | ||
| Q2 25 | $-28.9M | — | ||
| Q1 25 | $7.5M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-23.3M | — | ||
| Q2 24 | $21.6M | — | ||
| Q1 24 | $-31.5M | — |
| Q4 25 | 8.6% | 96.9% | ||
| Q3 25 | 20.9% | 84.2% | ||
| Q2 25 | -18.7% | — | ||
| Q1 25 | 6.0% | — | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | -16.5% | — | ||
| Q2 24 | 17.0% | — | ||
| Q1 24 | -28.5% | — |
| Q4 25 | 0.2% | 76.9% | ||
| Q3 25 | 0.2% | 52.5% | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 9.62× | 6.20× | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
KYIV
Segment breakdown not available.
